Market Access Overview

Executive Summary

MAP Brazil introduces you to the main processes involved in obtaining access, pricing and reimbursement in this major global market for pharmaceuticals. We also describe the important bodies encountered in launching a product in Brazil: the Brazilian Health Regulatory Agency (ANVISA), the Pharmaceutical Market Regulation Council (CMED), the Ministry of Health (MoH), and the process health technology assessment reviews from CONITEC.